OpenVSafe by OpenVAERS
Search V-safe

9TW-18160-03485

2 vaccinations 4 coded responses 21 check-ins 4 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
652 / MO
Registered
2021-02-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-05
    Registered in v-safe
  2. 2021-02-05
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-05
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches
    Adult check-in
  5. 2021-02-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-02-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-12
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-19
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-26
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-02-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-03-05
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-12
    Survey response — day 14, dose 2
    MedDRA: Throat irritation — Feeling: Fair · Be unable to work
    Free text: Scratchy throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-03-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-03-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-04-02
    Survey response — day 35, dose 2
    MedDRA: Fatigue, Pre-existing disease — Feeling: Fair
    Free text: Significant fatigue upon exertion. This has been building over the last couple of months, since the first vaccination. I must say, too, that theres concurrently a non-anemic macrocytisis, first noted 8 months ago, that Im being further assessed
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-05-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-08-29
    Survey response — 6 months, dose 2
    MedDRA: Chronic lymphocytic leukaemia, Immunisation reaction, Monoclonal B-cell lymphocytosis — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Monoclonal B-Cell Lymphocytosis, CLL type. This is suspicious for a vaccine adverse event (my physician agrees) in that situation had had 3 normal lymphocyte counts between Oct. & Dec. 20, just prior to mRNA vaccine.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-08-29
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-12-14
  26. 2021-12-28
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  27. 2022-02-26
    Survey response — 12 months, dose 2
    MedDRA: Monoclonal B-cell lymphocytosis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Monoclonal B cell Lymphocytosis
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-02-26
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  29. 2022-03-04

Vaccinations

DoseDateManufacturerCo-administered
12021-02-05Pfizer-BioNTech
22021-02-26Pfizer-BioNTech

Call center

2 call center cases

1 successful · 1 unsuccessful

VAERS report filed, before or during a call: 2

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — day 14, dose 2

2021-03-12

Symptoms: Scratchy throat

Release 6 — day 35, dose 2

2021-04-02

Symptoms: Significant fatigue upon exertion. This has been building over the last couple of months, since the first vaccination. I must say, too, that theres concurrently a non-anemic macrocytisis, first noted 8 months ago, that Im being further assessed

Release 9 — 6 months, dose 2

2021-08-29

Symptoms: Monoclonal B-Cell Lymphocytosis, CLL type. This is suspicious for a vaccine adverse event (my physician agrees) in that situation had had 3 normal lymphocyte counts between Oct. & Dec. 20, just prior to mRNA vaccine.

Release 11 — 12 months, dose 2

2022-02-26

Symptoms: Monoclonal B cell Lymphocytosis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChronic lymphocytic leukaemia ✓ · ✓
SDFatigue ✓ ✓ ✓
SDImmunisation reaction ✓ · ✓
SDMonoclonal B-cell lymphocytosis ✓ · ✓
SDPre-existing disease ✓ · ✓
SDThroat irritation ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release